Defyrus collaborates with National Institute of Allergy and Infectious Disease (NIAID), an institute of the National Institutes of Health (NIH), Washington, DC. Defence Research & Development Canada (DRDC), Suffield, Alberta and Defence Science & Technology Laboratories (DSTL) Porton Down, UK to develop anti-viral drugs and vaccines.

Defyrus is a private, Canadian life science company funded by Tancho Innovation Capital (tanchocapital) and investors from North America and Europe.